Financhill
Buy
68

DOCS Quote, Financials, Valuation and Earnings

Last price:
$55.22
Seasonality move :
-1.34%
Day range:
$52.60 - $54.00
52-week range:
$22.96 - $61.75
Dividend yield:
0%
P/E ratio:
61.56x
P/S ratio:
20.76x
P/B ratio:
10.40x
Volume:
1.6M
Avg. volume:
2.1M
1-year change:
87.54%
Market cap:
$10B
Revenue:
$475.4M
EPS (TTM):
$0.87

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DOCS
Doximity
$152.6M $0.33 12.82% 39.65% $55.25
DRIO
DarioHealth
$7.4M -$0.16 104.95% -60.98% $3.50
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$3.1M -- -13% -- --
SPOK
Spok Holdings
$35.5M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DOCS
Doximity
$53.56 $55.25 $10B 61.56x $0.00 0% 20.76x
DRIO
DarioHealth
$0.82 $3.50 $28M -- $0.00 0% 1.28x
FOXO
FOXO Technologies
$0.29 -- $5.1M -- $0.00 0% 2.17x
OTRK
Ontrak
$1.85 -- $7.8M -- $0.00 0% 0.64x
SPOK
Spok Holdings
$15.92 -- $322.7M 21.81x $0.31 7.85% 2.37x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DOCS
Doximity
-- 2.384 -- 7.03x
DRIO
DarioHealth
33.03% -0.172 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 17.369 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.339 95.85% 0.98x
SPOK
Spok Holdings
-- 0.549 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DOCS
Doximity
$123.2M $55.4M 19.29% 19.29% 40.52% $66.8M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

Doximity vs. Competitors

  • Which has Higher Returns DOCS or DRIO?

    DarioHealth has a net margin of 32.27% compared to Doximity's net margin of -166.11%. Doximity's return on equity of 19.29% beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About DOCS or DRIO?

    Doximity has a consensus price target of $55.25, signalling upside risk potential of 3.13%. On the other hand DarioHealth has an analysts' consensus of $3.50 which suggests that it could grow by 326.31%. Given that DarioHealth has higher upside potential than Doximity, analysts believe DarioHealth is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 12 0
    DRIO
    DarioHealth
    3 0 0
  • Is DOCS or DRIO More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.395, suggesting its more volatile than the S&P 500 by 39.491%.

  • Which is a Better Dividend Stock DOCS or DRIO?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or DRIO?

    Doximity quarterly revenues are $136.8M, which are larger than DarioHealth quarterly revenues of $7.4M. Doximity's net income of $44.2M is higher than DarioHealth's net income of -$12.3M. Notably, Doximity's price-to-earnings ratio is 61.56x while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 20.76x versus 1.28x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    20.76x 61.56x $136.8M $44.2M
    DRIO
    DarioHealth
    1.28x -- $7.4M -$12.3M
  • Which has Higher Returns DOCS or FOXO?

    FOXO Technologies has a net margin of 32.27% compared to Doximity's net margin of -162.71%. Doximity's return on equity of 19.29% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About DOCS or FOXO?

    Doximity has a consensus price target of $55.25, signalling upside risk potential of 3.13%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Doximity has higher upside potential than FOXO Technologies, analysts believe Doximity is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 12 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is DOCS or FOXO More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or FOXO?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or FOXO?

    Doximity quarterly revenues are $136.8M, which are larger than FOXO Technologies quarterly revenues of $1.2M. Doximity's net income of $44.2M is higher than FOXO Technologies's net income of -$1.9M. Notably, Doximity's price-to-earnings ratio is 61.56x while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 20.76x versus 2.17x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    20.76x 61.56x $136.8M $44.2M
    FOXO
    FOXO Technologies
    2.17x -- $1.2M -$1.9M
  • Which has Higher Returns DOCS or OTRK?

    Ontrak has a net margin of 32.27% compared to Doximity's net margin of -217.21%. Doximity's return on equity of 19.29% beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About DOCS or OTRK?

    Doximity has a consensus price target of $55.25, signalling upside risk potential of 3.13%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 116.22%. Given that Ontrak has higher upside potential than Doximity, analysts believe Ontrak is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 12 0
    OTRK
    Ontrak
    0 0 0
  • Is DOCS or OTRK More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.540, suggesting its more volatile than the S&P 500 by 154.002%.

  • Which is a Better Dividend Stock DOCS or OTRK?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or OTRK?

    Doximity quarterly revenues are $136.8M, which are larger than Ontrak quarterly revenues of $2.6M. Doximity's net income of $44.2M is higher than Ontrak's net income of -$5.6M. Notably, Doximity's price-to-earnings ratio is 61.56x while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 20.76x versus 0.64x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    20.76x 61.56x $136.8M $44.2M
    OTRK
    Ontrak
    0.64x -- $2.6M -$5.6M
  • Which has Higher Returns DOCS or SPOK?

    Spok Holdings has a net margin of 32.27% compared to Doximity's net margin of 10.5%. Doximity's return on equity of 19.29% beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About DOCS or SPOK?

    Doximity has a consensus price target of $55.25, signalling upside risk potential of 3.13%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -5.78%. Given that Doximity has higher upside potential than Spok Holdings, analysts believe Doximity is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 12 0
    SPOK
    Spok Holdings
    0 0 0
  • Is DOCS or SPOK More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.754%.

  • Which is a Better Dividend Stock DOCS or SPOK?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.85% to investors and pays a quarterly dividend of $0.31 per share. Doximity pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or SPOK?

    Doximity quarterly revenues are $136.8M, which are larger than Spok Holdings quarterly revenues of $34.9M. Doximity's net income of $44.2M is higher than Spok Holdings's net income of $3.7M. Notably, Doximity's price-to-earnings ratio is 61.56x while Spok Holdings's PE ratio is 21.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 20.76x versus 2.37x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    20.76x 61.56x $136.8M $44.2M
    SPOK
    Spok Holdings
    2.37x 21.81x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Carlos Slim Buy PBF Energy?
Why Did Carlos Slim Buy PBF Energy?

Carlos Slim made a splash in a surprising sector last…

Is Booking Holdings Stock Undervalued?
Is Booking Holdings Stock Undervalued?

There is a lot of humdrum in the market about…

Broadcom vs American Express: Which Is Best?
Broadcom vs American Express: Which Is Best?

Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
47
DRUG alert for Jan 3

Bright Minds Biosciences [DRUG] is down 4.28% over the past day.

Buy
88
BMA alert for Jan 3

Banco Macro SA [BMA] is up 0.88% over the past day.

Sell
50
AGFY alert for Jan 3

Agrify [AGFY] is down 5.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock